SCHEMBL20036375

SCHEMBL20036375

C=C(C)Oc1ccc(N)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 6/20 0.48
MAPK1 P28482 2/20 0.48
ALDH1A1 P00352 5/20 0.46
CYP3A4 P08684 2/20 0.46
TSHR P16473 2/20 0.46
TEAD4 Q15561 1/20 0.43
MAPT P10636 5/20 0.41
POLB P06746 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.40
MAOA P21397 2/20 0.39
KDM4E B2RXH2 1/20 0.39
GLA P06280 1/20 0.39
GAA P10253 1/20 0.39
THRB P10828 1/20 0.39
BLM P54132 1/20 0.39
CASP6 P55212 1/20 0.39
GFER P55789 1/20 0.39
NPC1 O15118 1/20 0.39
HPGD P15428 1/20 0.39
RAB9A P51151 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11144108 0.87 LMNA (0.44) ALDH1A1CYP3A4MAPTPOLBSMN1; SMN2
SCHEMBL1263025 0.79 ELANE (0.59) TDP1MAPK1ALDH1A1CYP3A4TSHR
SCHEMBL8975663 0.78 TDP1 (0.48) TDP1MAPK1ALDH1A1CYP3A4TSHR
SCHEMBL12862164 0.78 CA1 (0.55) TDP1MAPK1ALDH1A1CYP3A4MAPT
SCHEMBL28080298 0.78 ESR2 (0.48) ALDH1A1CYP3A4MAPTKDM4EGAA
SCHEMBL10725365 0.78 LMNA (0.60) TDP1ALDH1A1CYP3A4TSHRTEAD4
SCHEMBL16417752 0.77 SMN1; SMN2 (0.46) ALDH1A1MAPTSMN1; SMN2KDM4ETHRB
Ethylene SCHEMBL4257350 0.77 LMNA (0.59) TDP1MAPK1ALDH1A1CYP3A4MAPT
SCHEMBL12644763 0.76 NFE2L2 (0.39) ALDH1A1SMN1; SMN2MAOAKDM4EHPGD
SCHEMBL13893604 0.76 KMT2A (0.43) CYP3A4MAPTSMN1; SMN2MAOAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021219647-A1 METHOD FOR THE CONTINUOUS SYNTHESIS OF PARACETAMOL IPSOMEDIC (FR) 2021-11-04 WO disclosed
EP-3305784-A1 HAPTENS OF QUETIAPINE FOR USE IN IMMUNOASSAYS Janssen Pharmaceutica NV (BE) 2018-04-11 EP disclosed